Dudediligence.

Rezolute, Inc

RZLTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$15.4MSep ’24−$15.7MDec ’24−$18.9MMar ’25−$24.4MJun ’25−$18.1MSep ’25−$22.8MDec ’25−$16.2MMar ’26−$20.5MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Operating income−$41.8M−$56.0M−$70.4M−$79.9M−$83.0M
Net income−$41.1M−$51.8M−$68.5M−$74.4M−$77.6M
Operating cash flow−$39.6M−$44.5M−$57.4M−$69.1M−$64.6M
Free cash flownone on file−$44.6Mnone on filenone on filenone on file
Cash$150.4M$16.0M$70.4M$94.1M$10.6M
Shares outstanding33.6M36.8M53.2M87.0M96.4M